Naziv |
Akcije |
(KroHem) Mitrović, Zdravko ; Dujmović, Dino ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Gaćina, Petar ; Periša, Vlatka ; Prka, Željko ; Dreta, Barbara ; Galušić Davor ; Holik, Hrvoje et al.
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7. doi: 10.1111/ejh.13957 |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Ivić, Marija ; Fazlić Džankić, Amina ; Jonjić, Željko ; Mitrović, Zdravko ; Prka, Željko ; Piršić, Mario ; Jakšić, Ozren ; Gaćina, Petar et al.
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients // Wiener klinische Wochenschrift, 134 (2022), 1-2; 80-82. doi: 10.1007/s00508-021-01850-x |
|
Sabljić, Anica ; Sedinić Lacko, Martina ; Kušec, Rajko ; Pejša, Vlatko ; Lucijanić, Marko
No Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA- EPOCH // Pharmacology, 107 (2022), 11-12; 623-627. doi: 10.1159/000526625 |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Sedinić, Martina ; Kovačević, Stjepan ; Atić, Armin ; Pejša, Vlatko ; Kušec, Rajko
Baseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes // Leukemia & lymphoma, 63 (2022), 7; 1556-1565. doi: 10.1080/10428194.2022.2034160 |
|
Galušić, Davor ; Bašić-Kinda, Sandra ; Pijuk, Anđela ; Milunović, Vibor ; Dreta, Barbara ; Franjić, Neven ; Coha, Božena ; Sinčić-Petričević, Jasminka ; Gaćina, Petar ; Pejša, Vlatko et al.
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6. doi: 10.1097/HS9.0000000000000807 |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Ivić, Marija ; Fazlić Džankić, Amina ; Kušec, Rajko ; Pejša, Vlatko
Perirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients // Hematological oncology, 39 (2021), 4; 575-579. doi: 10.1002/hon.2887 |
|
Bašić-Kinda, Sandra ; Hude, Ida ; Ranković, Ena ; Ostojić-Kolonić, Slobodanka ; Pejša, Vlatko ; Radman, Ivo ; Bogeljić-Patekar, Martina ; Jakšić, Ozren ; Dubravčić, Klara ; Franić-Šimić, Ivana et al.
Comparison of different schedules of rituximab and chlorambucil in previously untreated chronic lymphocytic leukemia: a retrospective study of Krohem // Journal of cancer science and clinical therapeutics, 5 (2021), 4; 426-433. doi: 10.26502/jcsct.5079128 |
|
Lucijanić, Marko ; Krečak, Ivan ; Galušić, Davor ; Sedinić, Martina ; Holik Hrvoje ; Periša, Vlatka ; Morić Perić, Martina ; Zekanović, Ivan ; Štoos- Veić, Tajana ; Pejša, Vlatko et al.
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis // Wiener klinische Wochenschrift, 133 (2021), 3-4; 97-103. doi: 10.1007/s00508-020-01802-x |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Sedinić, Martina ; Kušec, Rajko ; Pejša, Vlatko
More pronounced muscle loss during immunochemotherapy is associated with worse clinical outcomes in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features // Therapeutics and clinical risk management, 17 (2021), 1037-1044. doi: 10.2147/tcrm.s323749 |
|
Lucijanić, Marko ; Huzjan Korunić, Renata ; Sedinić, Martina ; Kušec, Rajko ; Pejša, Vlatko
Prognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type // Leukemia & lymphoma, 62 (2021), 10; 2535-2538. doi: 10.1080/10428194.2021.1919667 |
|